References
- Perez C, Sutow W W, Wang Y M. Evaluation of overall toxicity of high-dosage methotrexate regimens. Med Pediatr Oncol 1979; 6: 219–28
- Umeda T, Takada N, Hodaka E, Endo F, Ishii T. Clinical evaluation of severe toxicity in 54 patients with osteosarcoma receiving high-dose methotrexate therapy in the 365 courses. Jpn J Cancer Chemother 1984; 11: 285–94, (in Japanese)
- Ellison N M, Servi R J. Acute renal failure and death following sequential intermediate-dose methotrexate and 5-FU. An adverse effect due to concomitant indomethacin administration. Cancer Treat Rep 1985; 69: 342–3
- Goldberg N H, Romolo J L, Austin E H, Drake J, Rosenberg M D. Anaphylactoid type reactions in two patients receiving high dose intravenous methotrexate. Cancer 1978; 41: 52–5
- Costa M D, Isacoff W, Rothenberg S P, Perwaiz M. Protein-methotrexate-IgG complexes in the serum of patients receiving high-dose antifolate therapy. Cancer 1980; 46: 471–4
- Haim N, Kedar A, Robinson E. Methotrexate-related deaths in patients previously treated with cis-diamminedichloride platinum. Cancer Chemother Pharmacol 1984; 13: 223–5